Previous Close | 0.6873 |
Open | 0.7300 |
Bid | 0.0000 x 1000 |
Ask | 0.0000 x 800 |
Day's Range | 0.6800 - 0.7300 |
52 Week Range | 0.4810 - 4.1900 |
Volume | |
Avg. Volume | 114,091 |
Market Cap | 20.296M |
Beta (5Y Monthly) | 0.63 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.4020 |
Earnings Date | Aug 16, 2022 - Aug 20, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for NAOV
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
ELMSFORD, N.Y., July 12, 2022--NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced its Australian distributor, DukeHill HC, is launching a series of educational webinars to present the Company’s UroShield technology to clinicians. The series, which will feature clinicians and patients’ experiences, seeks to inform clinicians about the use, benefits and outcomes achieved
ELMSFORD, N.Y., June 29, 2022--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced it is shifting the majority of its manufacturing operations to Singapore in order to allow scalability increase efficiency and address potential supply chain delays.